LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 292 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,111,000 | +150.8% | 8,162 | +123.5% | 0.02% | +122.2% |
| Q2 2017 | $443,000 | -78.8% | 3,652 | -81.1% | 0.01% | -94.4% |
| Q4 2015 | $2,092,000 | +484.4% | 19,293 | +362.2% | 0.16% | +184.2% |
| Q3 2015 | $358,000 | -92.5% | 4,174 | -91.2% | 0.06% | -70.0% |
| Q2 2015 | $4,772,000 | – | 47,295 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |